Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Essential Psychopharmacology
|
July 27, 2005
Study designs and outcomes in antidepressant clinical trials
Arif Khan, Kelly Schwartz
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
April 25, 2007
Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports
Arif Khan, Kelly Schwartz
Current Opinion in Microbiology
|
January 15, 2013
Microbial amyloids--functions and interactions within the host
Kelly Schwartz, Blaise R Boles
Biological Psychiatry
|
December 5, 2006
Relationship between depression severity entry criteria and antidepressant clinical trial outcomes
Arif Khan, Kelly Schwartz, Russell L Kolts, et al.
Journal of Visualized Experiments : Jove
|
January 6, 2011
The use of drip flow and rotating disk reactors for Staphylococcus aureus biofilm analysis
Kelly Schwartz, Rachel Stephenson, Margarita Hernandez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 23, 2007
Psychiatric diagnosis and clinical trial completion rates: analysis of the FDA SBA reports
Arif Khan, Kelly Schwartz, Nick Redding, et al.
Plos Pathogens
|
July 14, 2011
Hemoglobin promotes Staphylococcus aureus nasal colonization
Melissa Pynnonen, Rachel E Stephenson, Kelly Schwartz, et al.
Molecular Microbiology
|
September 15, 2015
Extracellular DNA facilitates the formation of functional amyloids in Staphylococcus aureus biofilms
Kelly Schwartz, Mahesh Ganesan, David E Payne, et al.
Plos Pathogens
|
June 12, 2012
Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms
Kelly Schwartz, Adnan K Syed, Rachel E Stephenson, et al.
The Journal of Clinical Psychiatry
|
December 29, 2007
Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials
Arif Khan, Kelly Schwartz, Chelsea Stern, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Essential Psychopharmacology
|
July 27, 2005
Study designs and outcomes in antidepressant clinical trials
Arif Khan, Kelly Schwartz
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
April 25, 2007
Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports
Arif Khan, Kelly Schwartz
Current Opinion in Microbiology
|
January 15, 2013
Microbial amyloids--functions and interactions within the host
Kelly Schwartz, Blaise R Boles
Biological Psychiatry
|
December 5, 2006
Relationship between depression severity entry criteria and antidepressant clinical trial outcomes
Arif Khan, Kelly Schwartz, Russell L Kolts, et al.
Journal of Visualized Experiments : Jove
|
January 6, 2011
The use of drip flow and rotating disk reactors for Staphylococcus aureus biofilm analysis
Kelly Schwartz, Rachel Stephenson, Margarita Hernandez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 23, 2007
Psychiatric diagnosis and clinical trial completion rates: analysis of the FDA SBA reports
Arif Khan, Kelly Schwartz, Nick Redding, et al.
Plos Pathogens
|
July 14, 2011
Hemoglobin promotes Staphylococcus aureus nasal colonization
Melissa Pynnonen, Rachel E Stephenson, Kelly Schwartz, et al.
Molecular Microbiology
|
September 15, 2015
Extracellular DNA facilitates the formation of functional amyloids in Staphylococcus aureus biofilms
Kelly Schwartz, Mahesh Ganesan, David E Payne, et al.
Plos Pathogens
|
June 12, 2012
Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms
Kelly Schwartz, Adnan K Syed, Rachel E Stephenson, et al.
The Journal of Clinical Psychiatry
|
December 29, 2007
Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials
Arif Khan, Kelly Schwartz, Chelsea Stern, et al.
Page
of 2